TAK
Price
$15.09
Change
-$0.03 (-0.20%)
Updated
Sep 17 closing price
Capitalization
47.82B
42 days until earnings call
ZTS
Price
$146.93
Change
-$0.53 (-0.36%)
Updated
Sep 17 closing price
Capitalization
65.35B
42 days until earnings call
Interact to see
Advertisement

TAK vs ZTS

Header iconTAK vs ZTS Comparison
Open Charts TAK vs ZTSBanner chart's image
Takeda Pharmaceutical
Price$15.09
Change-$0.03 (-0.20%)
Volume$3.6M
Capitalization47.82B
ZOETIS
Price$146.93
Change-$0.53 (-0.36%)
Volume$1.96M
Capitalization65.35B
TAK vs ZTS Comparison Chart in %
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TAK vs. ZTS commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TAK is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (TAK: $15.09 vs. ZTS: $146.93)
Brand notoriety: TAK: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TAK: 86% vs. ZTS: 64%
Market capitalization -- TAK: $47.82B vs. ZTS: $65.35B
TAK [@Pharmaceuticals: Generic] is valued at $47.82B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $65.35B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.35B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TAK’s FA Score shows that 2 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • TAK’s FA Score: 2 green, 3 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, both TAK and ZTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • TAK’s TA Score: 5 bullish, 5 bearish.
  • ZTS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both TAK and ZTS are a bad buy in the short-term.

Price Growth

TAK (@Pharmaceuticals: Generic) experienced а -1.31% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +26.07%. For the same industry, the average monthly price growth was +25.64%, and the average quarterly price growth was +59.72%.

Reported Earning Dates

TAK is expected to report earnings on Oct 30, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+26.07% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($65.4B) has a higher market cap than TAK($47.8B). TAK has higher P/E ratio than ZTS: TAK (52.02) vs ZTS (25.29). TAK YTD gains are higher at: 13.973 vs. ZTS (-8.939). TAK has higher annual earnings (EBITDA): 1.13T vs. ZTS (4.02B). TAK has more cash in the bank: 419B vs. ZTS (1.44B). ZTS has less debt than TAK: ZTS (6.79B) vs TAK (4.51T). TAK has higher revenues than ZTS: TAK (4.48T) vs ZTS (9.39B).
TAKZTSTAK / ZTS
Capitalization47.8B65.4B73%
EBITDA1.13T4.02B27,992%
Gain YTD13.973-8.939-156%
P/E Ratio52.0225.29206%
Revenue4.48T9.39B47,736%
Total Cash419B1.44B29,199%
Total Debt4.51T6.79B66,353%
FUNDAMENTALS RATINGS
TAK vs ZTS: Fundamental Ratings
TAK
ZTS
OUTLOOK RATING
1..100
6961
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8919
PRICE GROWTH RATING
1..100
5763
P/E GROWTH RATING
1..100
3086
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (5) in the Pharmaceuticals Major industry is in the same range as ZTS (33) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to ZTS’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is significantly better than the same rating for TAK (89) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew significantly faster than TAK’s over the last 12 months.

TAK's Price Growth Rating (57) in the Pharmaceuticals Major industry is in the same range as ZTS (63) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to ZTS’s over the last 12 months.

TAK's P/E Growth Rating (30) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (86) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAKZTS
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
62%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
37%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 8 days ago
42%
Bullish Trend 14 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bearish Trend 3 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NBET32.880.15
+0.47%
Neuberger Berman Engy Trnstn & InfrasETF
JHMM64.370.03
+0.05%
JHancock Multifactor Mid Cap ETF
KONG30.37-0.02
-0.06%
Formidable Fortress ETF
PTBD19.89-0.05
-0.23%
Pacer Trendpilot US Bond ETF
DNL40.75-0.11
-0.27%
WisdomTree Global ex-US Qual Div Gr ETF

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.20%
HLN - TAK
41%
Loosely correlated
+1.29%
SGIOY - TAK
41%
Loosely correlated
-0.10%
ESAIY - TAK
35%
Loosely correlated
-1.70%
BNXTF - TAK
32%
Poorly correlated
-2.45%
ZTS - TAK
30%
Poorly correlated
-0.36%
More